Found: 11
Select item for more details and to access through your institution.
The evolution of tafenoquine--antimalarial for a new millennium?
- Published in:
- Journal of the Royal Society of Medicine, 1999, v. 92, n. 7, p. 345, doi. 10.1177/014107689909200705
- By:
- Publication type:
- Article
Epiartemisinin, a Remarkably Poor Antimalarial: Implications for the Mode of Action.
- Published in:
- Helvetica Chimica Acta, 2000, v. 83, n. 6, p. 1239, doi. 10.1002/1522-2675(20000607)83:6<1239::AID-HLCA1239>3.0.CO;2-S
- By:
- Publication type:
- Article
Synthesis, Structure, and Antimalarial Activity of Some Enantiomerically Pure, cis-fused cyclopenteno-1,2,4-trioxanes.
- Published in:
- Helvetica Chimica Acta, 1995, v. 78, n. 3, p. 647, doi. 10.1002/hlca.19950780312
- By:
- Publication type:
- Article
Synthesis of New 1,2,4-Trioxanes and their Antimalarial Activity.
- Published in:
- Helvetica Chimica Acta, 1988, v. 71, n. 7, p. 1805, doi. 10.1002/hlca.19880710722
- By:
- Publication type:
- Article
Titelbild: Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class (Angew. Chem. 13/2006).
- Published in:
- Angewandte Chemie, 2006, v. 118, n. 13, p. 2041, doi. 10.1002/ange.200690045
- By:
- Publication type:
- Article
Artemisone—A Highly Active Antimalarial Drug of the Artemisinin ClassWork at the HKUST was funded by Bayer AG Central Research, Leverkusen, the Institute of Molecular Technology for Drug Discovery and Synthesis through the HKSAR University Grants Committee Areas of Excellence Fund, and the HKSAR Research Grants Council through the Competitive Earmarked Research Grants Scheme. The Medicines for Malaria Venture (MMV), Geneva, also provided financial support of the work at Bayer, and through Bayer at HKUST and other centers. Dr. W. Collins (Centers for Disease Control, Atlanta) supplied P. falciparum FVO strain used for the primate studies.
- Published in:
- Angewandte Chemie, 2006, v. 118, n. 13, p. 2136, doi. 10.1002/ange.200503071
- By:
- Publication type:
- Article
Highly Antimalaria-Active Artemisinin Derivatives: Biological Activity Does Not Correlate with Chemical Reactivity ( This work was supported by grants from Bayer AG (Leverkusen, Germany) and by the Government of the HKSAR University Grants Council (grant no. HKUST 6091/02P). )
- Published in:
- Angewandte Chemie, 2004, v. 116, n. 11, p. 1405, doi. 10.1002/ange.200352343
- By:
- Publication type:
- Article
Cover Picture: Artemisone—A Highly Active Antimalarial Drug of the Artemisinin Class (Angew. Chem. Int. Ed. 13/2006).
- Published in:
- Angewandte Chemie International Edition, 2006, v. 45, n. 13, p. 1989, doi. 10.1002/anie.200690045
- By:
- Publication type:
- Article
Artemisone—A Highly Active Antimalarial Drug of the Artemisinin ClassWork at the HKUST was funded by Bayer AG Central Research, Leverkusen, the Institute of Molecular Technology for Drug Discovery and Synthesis through the HKSAR University Grants Committee Areas of Excellence Fund, and the HKSAR Research Grants Council through the Competitive Earmarked Research Grants Scheme. The Medicines for Malaria Venture (MMV), Geneva, also provided financial support of the work at Bayer, and through Bayer at HKUST and other centers. Dr. W. Collins (Centers for Disease Control, Atlanta) supplied P. falciparum FVO strain used for the primate studies.
- Published in:
- Angewandte Chemie International Edition, 2006, v. 45, n. 13, p. 2082, doi. 10.1002/anie.200503071
- By:
- Publication type:
- Article
Highly Antimalaria-Active Artemisinin Derivatives: Biological Activity Does Not Correlate with Chemical Reactivity ( This work was supported by grants from Bayer AG (Leverkusen, Germany) and by the Government of the HKSAR University Grants Council (grant no. HKUST 6091/02P). )
- Published in:
- Angewandte Chemie International Edition, 2004, v. 43, n. 11, p. 1381, doi. 10.1002/anie.200352343
- By:
- Publication type:
- Article
Convenient Access Both to Highly Antimalaria-Active 10-Arylaminoartemisinins, and to 10-Alkyl Ethers Including Artemether, Arteether, and Artelinate.
- Published in:
- ChemBioChem, 2005, v. 6, n. 4, p. 659, doi. 10.1002/cbic.200400366
- By:
- Publication type:
- Article